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a b s t r a c t
To prevent the spread of infection, an invading pathogen must ﬁrst be recognized by the innate immune
system. Host pattern recognition receptors detect distinct pathogen-associated molecules and induce the
transcription and release of interferon and inﬂammatory molecules to resolve infection. Unlike
infections with pathogens that replicate autonomously from the host, viral infections blur the
boundaries of self and non-self. Differentiation of host from virus is achieved by restricting localization
of host nucleic acids and by placing pattern recognition receptors in speciﬁc subcellular compartments.
Within this review, we discuss how several families of pattern recognition receptors act to provide a
comprehensive surveillance network that has the potential to induce interferon expression in response
to any viral infection.
& 2015 Elsevier Inc. All rights reserved.
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Introduction
The production of inﬂammatory cytokines and interferons
(IFNs) is triggered after detection of potentially infectious patho-
gens and is central to the innate immune response. Type-I IFNs
signal in an autocrine and paracrine fashion for the production of
hundreds of IFN stimulated genes (ISGs), many of which are still
uncharacterized (De Veer et al., 2001; Schoggins et al., 2011).
These ISGs play an important role in restricting viral replication
and stopping the spread of infection to other cells. Thus, detection
of a virus is a vital ﬁrst step towards immunity.
The innate immune system relies on its ability to recognize
general pathogen associated molecular patterns (PAMPs). PAMPs
are pathogen-derived molecules unique from the host and difﬁcult
to mutate or sequester from detection without a ﬁtness cost
(Medzhitov, 2009). These PAMPs are recognized by a limited
number of germline encoded pattern recognition receptors (PRRs).
The PAMPs detected are produced by a wide variety of pathogens,
thus allowing a single PRR to report on many infectious encoun-
ters. In the case of viral pathogens, the innate immune system
often detects the most intrinsic part of a virus, its nucleic acid
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genome. Viral genomes exist as RNA or DNA, are single or double-
stranded, and can be partitioned into one or more segments.
Nucleic acids are not unique to viruses since they are essential
to all cellular life. To differentiate between host and viral nucleic
acids, PRRs use two criteria to detect viral nucleic acids speciﬁcally.
The ﬁrst criteria is based on the intrinsic ability of PRRs to
recognize unusual biochemical features present in viral, but not
host, nucleic acids. For example, the PRR retinoic acid-inducible
gene 1 (RIG-I) detects RNAs that are tri- (or di-) phosphorylated,
and lack a 7-methylguanosine cap (Hornung et al., 2006; Pichlmair
et al., 2006; Rehwinkel et al., 2010; Goubau et al., 2014). Host
mRNAs are also tri-phosphorylated, but the presence of the cap
minimizes recognition by RIG-I. The second criteria that PRRs use
to detect viral nucleic acids speciﬁcally is based on the ability of
the host to restrict its own nucleic acids to speciﬁc locations
within the cell. For example, host DNA should not be found in the
cytoplasm of uninfected cells, and the PRR cyclic guanosine
monophosphate-adenosine monophosphate (cGAMP) synthase
(cGAS) detects cytoplasmic DNA, which is presumably of viral
origin (Sun et al., 2013; Wu et al., 2013).
In this review, we expand on the ideas described above as we
describe the PRRs of the innate immune system that function to
produce type-I IFNs. We focus on the three major IFN-inducing
families of PRRs in mammals, the Toll-like Receptors (TLRs), RIG-I-
like Receptors (RLRs) and cGAS (Fig. 1). We highlight how
differences in the subcellular localization of host and viral nucleic
acids, and the PRRs that detect them, can regulate the ability of the
host to activate an IFN response during a viral infection.
Toll-like Receptors
TLRs are PRRs that detect PAMPs derived from various microbes
and initiate the transcription of inﬂammatory cytokines and type-I
IFNs. These receptors are transmembrane proteins that contain an
extracellular/lumenal domain that consists of a series of leucine
rich repeats (LRRs). The LRR-containing domain detects PAMPs
either directly or through interactions with accessory proteins that
have high afﬁnity PAMP-binding activities. Several TLRs recognize
nucleic acids and have an important role in antiviral defense. For
example, TLR3 recognizes viral double stranded RNA (Alexopoulou
et al., 2001), TLR7 and TLR8 recognize viral single stranded RNA
(Diebold et al., 2004; Heil et al., 2004), and TLR9 recognizes DNA
containing unmethylated CpG motifs present in numerous viral and
non-viral pathogens (Lund et al., 2003; Redecke et al., 2001; Kaisho et
al., 2000). In addition, recent work identiﬁed murine TLR13 as a
nucleic acid sensor, but the ligand is a speciﬁc sequence present in
bacterial ribosomal RNA (Oldenburg et al., 2012). Thus, while most
nucleic acid sensing TLRs have an important role in detecting viruses,
at least one (TLR13) has a speciﬁc anti-bacterial function.
The nucleic acid sensing TLRs are localized to endolysosomes.
During an infection, viral particles are endocytosed. The acidiﬁca-
tion of endosomes allows for some viruses to uncoat and gain
entry into the cytoplasm. However, not all viral particles are
successful in the process. In the acidic environment of the
lysosome, viral particles are degraded and the genomic nucleic
acids are released, allowing for detection by TLRs. Thus, the nucleic
acid sensing TLRs are localized to compartments where viral
genomes can be exposed.
Binding to nucleic acids promotes interactions between two
TLRs, which consequently dimerize the Toll/Interleukin-1 Receptor
(TIR) domains present in the cytoplasmic tails of the receptors
(Latz et al., 2007). The dimerized TIRs serve as a platform to recruit
cytosolic adapter proteins that also contain TIR domains. Two
distinct sets of adapters are thought to be recruited to dimerized
TLRs. The most common set of adapters, utilized by all TLRs except
TLR3, is that of TIRAP and MyD88. The recruitment of these
adapters initiates the formation of a large helical oligomer called
the myddosome, which is functionally considered a supramolecu-
lar organizing center (SMOC) (Kagan et al., 2014). This SMOC
mediates kinase- and ubiquitin ligase-dependent events that
activate inﬂammatory transcription factors such as NF-κB and
Fig. 1. Multiple organelles initiate signal transduction that lead to type I IFN expression. Viruses can enter most cells through the endocytic pathway or by crossing the
plasma membrane. TLRs detect viral genomes in endosomes. Once in the cytoplasm, genomic viral RNA (vRNA) can be detected by the RLRs and activate type-I IFN through
MAVS, located on mitochondria and ER membranes. Genomic viral DNA (vDNA) is detected in the cytoplasm by cGAS or in the nucleus by IFI16. Both sensors activate STING
to induce type-I IFNs. cGAS and RLRs can also detect viral replication intermediates in viral factories. All pathways activate the IRF and NF-kB transcription factors to
stimulate IFNB transcription.
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IRF7. NF-κB and IRF7 then translocate into the nucleus to promote
the expression of IFNs and other inﬂammatory mediators. The
second set of adapters that control TLR signaling consists of TRAM
and TRIF, but these adapters are utilized by a small set of TLRs.
Whether TRAM and TRIF assemble a SMOC similar to the myddo-
some that activates inﬂammatory transcription factors is unclear,
although the use of SMOCs as signaling platforms in multiple PRR
pathways suggests that this may be the case (Kagan et al., 2014).
In order to minimize detection of host-encoded nucleic acids,
the nucleic acid-sensing TLRs are restricted to endolysosomal
compartments by a process mediated by UNC93B1. UNC93B1 is a
multipass membrane protein localized to the endoplasmic reticu-
lum (ER) that was identiﬁed because the H412R mutation in one of
its transmembrane domains abrogates IFN expression elicited by
TLR3, 7, and 9 agonists (Tabeta et al., 2006). This protein was
originally proposed to not have a function in TLR transport
throughout the cell (Tabeta et al., 2006). However, subsequent
work demonstrated that bone marrow derived dendritic cells with
the H412R mutation in UNC93B1 were defective in trafﬁcking TLR9
to endolysosomes (Kim et al., 2008). UNC93B1 and nucleic acid
sensing TLRs bind to each other in the ER, and the H412R mutation
ablates those interactions (Brinkmann et al., 2007). UNC93B1 loads
the nucleic acid sensing TLRs into COPII vesicles in order to bud
from the ER and travel through the Golgi complex, and TLR9
additionally requires the adapter protein-2 complex in order to
trafﬁc to endolysosomes (Lee et al., 2013).
In addition to being regulated by UNC93B1 trafﬁcking, TLR3, 7,
8, and 9 need to be cleaved by various proteases such as
cathepsins, asparagine endopeptidase, and furin-like proprotein
convertases (Ewald et al., 2008, 2011; Park et al., 2008; Sepulveda
et al., 2009; Garcia-Cattaneo et al., 2012; Maschalidi et al., 2012;
Hipp et al., 2013). The proteolysis occurs as the TLRs are trans-
ported through acidic endosomal compartments where these
enzymes are active. Although nucleic acids are capable of binding
to the unprocessed TLRs, downstream signaling cannot occur until
after proteolysis (Ewald et al., 2008). This proteolytic regulation is
particularly important to prevent autoimmunity. In the case of
systemic lupus erythromatitis, host nucleic acids are immunosti-
mulatory (Leadbetter et al., 2002). Having nucleic acid sensing
TLRs mislocalized to the plasma membrane increases the chances
of an autoimmune reaction (Barton et al., 2006). By designing TLRs
to remain incapable of being activated until they reach their
proper destination, the risk of autoimmunity is reduced.
Once in endosomes, nucleic acid sensing TLRs do not remain
static. TLR9 can trafﬁc to phagosomes that have been initiated by
FcγR signaling irrespective of DNA content (Henault et al., 2012).
Upon interaction with CpG DNA, TLR9 initiates a signaling path-
way that activates NF-κB-dependent cytokine and IFN expression
(Henault et al., 2012). Recent work has indicated that TLR9
activates cytokine expression and IFN expression from distinct
endosomal populations, with the latter requiring non-canonical
autophagy components to trafﬁc to a distinct vesicle (Henault
et al., 2012). Non-canonical autophagy does not form a double
membrane. Instead, the autophagy regulator LC3 binds TLR9-
containing phagosomes and somehow induces transport to dis-
tinct organelles where the IFN-inducing transcription factor IRF7
can become activated (Henault et al., 2012). This requirement for
moving TLR9 to induce IFNs is not unique to phagocytosed cargo.
Cargo that has been endocytosed instead of phagocytosed also
requires movement of TLR9 to induce type-I IFNs (Sasai et al.,
2010). However, in the case of endosomes, the movement of TLR9
depends upon activator protein-3 (AP-3) which trafﬁcs TLR9 to
lysosomal related organelles (LROs) where IRF7 can be activated
for IFN induction. Disruption of TLR9 movement in either of these
two trafﬁcking pathways by eliminating LC3 or AP-3 results in
blocking IFN induction without blocking the production of
inﬂammatory cytokines (Sasai et al., 2010). Although the work
published primarily focused on TLR9, some work with TLR3 and
7 ligands in the endocytic pathway suggest that they may be
regulated similarly (Sasai et al., 2010).
TLR3, 7, 8 and 9 all induce type-I IFNs in plasmacytoid dendritic
cells where they are expressed, but the signaling molecules
downstream differ between TLR3 and the others. TLR7, 8 and
9 utilize MyD88, and were recently found to also depend on TIRAP
for their signaling functions (Bonham et al., 2014). The require-
ment of TIRAP for signaling from TLR7 and TLR9 was originally
missed because experimental conditions utilizing synthetic
nucleic acids rather than viruses masked the requirement for
TIRAP (Yamamoto et al., 2002; Horng et al., 2002). TIRAP has a
lipid-binding domain that interacts promiscuously with acidic
phosphoinositides, allowing it to survey the plasma and endoso-
mal membranes for TLRs bound to ligand. TLR activation causes
TIRAP to oligomerize with MyD88 and IRAK kinases, thus creating
a SMOC called the myddosome that promotes the expression of
inﬂammatory cytokines and IFNs. In contrast, TLR3 engages only
the cytosolic adapter TRIF to induce cytokine and IFN expression
(Fitzgerald et al., 2003; Yamamoto et al., 2003). It is unclear why
TLR3 evolved to utilize TRIF instead of MyD88 to induce IFNs. One
possibility is that TLR3 resides in an endosomal population that
differs from TLR7 and TLR9, and thus may have access to different
sets of adapter proteins. In support of this idea, TLR3, TLR7, and
TLR9 trafﬁc to endosomes differently. TLR7 proceeds directly from
the trans-Golgi network to endosomes, whereas TLR3 is delivered
to the plasma membrane before reaching endosomes (Lee et al.,
2013; Pohar et al., 2013). However, TLR9, which signals via MyD88,
can also trafﬁc to the plasma membrane before its proteolytic
processing in endosomes (Lee et al., 2013). Additional studies that
identify the precise endosomal populations inhabited by nucleic
acid sensing TLRs would greatly beneﬁt this discussion.
In addition to the nucleic acid sensing TLRs, two TLRs localized
to the plasma membrane sense viral pathogens. Although TLR2
and TLR4 are better known to recognize bacterial lipoproteins and
lipopolysaccharides, respectively, these PRRs are also activated by
viral ligands. TLR4 can initiate TRIF-dependent signaling after
binding the glycoprotein of vesicular stomatitis virus (Georgel et
al., 2007). In a subset of inﬂammatory monocytes, TLR2 is
activated by mouse cytomegalovirus and vaccinia virus (Barbalat
et al., 2009). TLR2 is activated by additional viruses in other cell
types (Hoffmann et al., 2009; Michaud et al., 2010). Although these
PRRs are located at the plasma membrane, IFN-inducing signal
transduction occurs from endosomal compartments (Barbalat et
al., 2009; Dietrich et al., 2010). Whether TLR2 and TLR4 recognize
common molecular motifs among the viruses is currently
unknown.
RIG-I-like Receptors
TLRs are limited in their ability to detect viruses because they
only survey the extracellular space and are expressed in a limited
number of cell types. In contrast, the RLRs, RIG-I and melanoma
differentiation-associated protein 5 (MDA5), are expressed in
almost all cells. RIG-I and MDA5 are cytoplasmic RNA helicases
that recognize non-self RNA motifs. RIG-I binds 50 tri- and di-
phosphates present on short double stranded (ds) RNA whereas
MDA5 binds long dsRNA molecules (Hornung et al., 2006;
Pichlmair et al., 2006; Goubau et al., 2014; Kato et al., 2008,
2006; Gitlin et al., 2006; Wang et al., 2010; Lu et al., 2010; Luo
et al., 2011). RIG-I and MDA5 activate IRF3 and NF-κB through the
adapter, mitochondrial antiviral signaling protein (MAVS). RIG-I
and MDA5 form ﬁlaments upon RNA binding which oligomerizes
the RLR caspase recruitment domain (CARD), and enhances
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interactions with the MAVS CARD (Peisley et al., 2013, 2011; Wu et
al., 2013). The interaction between RLRs and MAVS CARDs leads to
the formation of a SMOC with prion-like properties on the surface
of mitochondria. The MAVS SMOC then functions to activate
transcription factors that induce type-I IFNs (Hou et al., 2011).
RNA viruses enter the cytoplasm after breaching plasma or
endosomal membranes. Unlike many DNA viruses, RNA viruses
must rely on their own enzymes for genome replication. Replica-
tion intermediates formed by these enzymes contain uncapped
RNA or have dsRNA character and can be recognized by RLRs. In
order to catalyze RNA replication, RNA viruses may set up
organelle-like replication complexes in the cytoplasm. These viral
“factories” are composed of cellular membranes, usually ER-
derived, but examples can be found for viruses utilizing the Golgi
and lysosomal compartment as well (Den Boon et al., 2004).
Mitochondria are also recruited to sites of RNA virus replication
presumably to take advantage of mitochondrial ATP production
during RNA replication (Novoa et al., 2005).
Intriguingly, MAVS is situated at the same membranes that
many RNA viruses exploit for their replication, namely the mito-
chondria, peroxisomes and mitochondrial-associated ER mem-
branes (MAM), which are tethered to mitochondria and
peroxisomes by the protein mitofusin 2 (MFN2) (De Brito and
Scorrano 2008). MAVS on the mitochondria and peroxisomes
induce different types of IFN. Mitochondrial MAVS induces both
type-I and type-III, whereas peroxisomal MAVS induces type-III
IFN (Odendall et al., 2014; Dixit et al., 2010). It has been proposed
that the MAM coordinates MAVS-dependent responses from
mitochondria and peroxisomes (Horner et al., 2011). Viral antago-
nists that target MAVS can lead to a profound loss of signaling
while only inactivating a small pool of MAVS in a cell (Horner
et al., 2011; Meylan et al., 2005; Li et al., 2005). These observations
suggest that the distribution of MAVS on multiple organelles is not
redundant, but is rather a functionally important aspect of the RLR
network that promotes antiviral immunity (Horner et al., 2011;
Li et al., 2005).
STING pathway
While RLRs and MAVS produce IFN in response to viral RNA, a
parallel pathway detects intracellular viral DNA. Stimulator of IFN
genes (STING) is an ER-localized protein that coordinates the type-
I IFN response to viral DNA (Ishikawa et al., 2009; Ishikawa and
Barber 2008). While many DNA sensors have been proposed to
activate STING (Goubau et al., 2013), only cGAS has a clear
mechanism of STING activation. cGAS is a cytoplasmic protein
that recognizes B-form DNA. Upon binding to these ligands, cGAS
synthesizes the cyclic dinucleotide cGAMP, which binds and
activates STING to promote IFN gene expression (Sun et al.,
2013; Wu et al., 2013). Intermediates of the retroviral replication
cycle, namely RNA:DNA hybrids, have also been proposed to
activate cGAS. In vitro, cGAS can synthesize cGAMP in response
to synthetic RNA:DNA ligands (Jakobsen et al., 2013; Mankan et al.,
2014; Rigby et al., 2014), but it is unclear if cGAS-dependent
signaling can occur and if cGAS is activated in response to natural
RNA:DNA ligands. Some bacteria also synthesize cyclic dinucleo-
tides through the actions of a prokaryotic cGAS-like enzyme. These
bacterial dinucleotides can activate STING (Burdette et al., 2011).
While both cGAMP and bacterial dinucleotides bind STING and
activate type-I IFN, cGAMP binds STING at a higher afﬁnity due to
its noncanonical 20-50 phosphodiester linkage (Diner et al., 2013;
Ablasser et al., 2013; Zhang et al., 2013; Gao et al., 2013).
In order to induce IFNs, STING must trafﬁc from the ER to
vesicles (Saitoh et al., 2009; Konno et al., 2013). This movement
appears to be orchestrated by proteins involved in the autophagy
pathway (Saitoh et al., 2009; Konno et al., 2013). Upon binding
dinucleotides, STING moves from the ER to the Golgi via a
mechanism dependent on VPS34, a Class III PI3K that regulates
many pathways including endocytic trafﬁcking (Konno et al., 2013;
Jaber et al., 2012). STING then leaves the Golgi and associates with
TBK1 on vesicles to activate IRF3 and NF-κB (Ishikawa and Barber
2008). The speciﬁc identity of these IFN-inducing vesicles remains
undeﬁned. After ATG9 depletion, STING and TBK-1 still trafﬁc to
vesicles, but more type-I IFN is induced than wild-type cells,
implying that ATG9 or autophagy negatively regulates STING
activation of TBK-1 (Saitoh et al., 2009). ULK1, another kinase
involved in autophagy, phosphorylates human and mouse STING
at serine 366 and 365 respectively to negatively regulate cGAMP-
induced STING signaling (Konno et al., 2013). Knockdown of ULK1
leads to loss of phosphorylation of serine 366/365, which ulti-
mately prevents STING degradation and sustains IFN expression
(Konno et al., 2013). STING is likely degraded by autophagy in the
autolysosome because after activation, STING associates with LC3
and p62/SQSTM1, proteins that target cargo for autophagy (Saitoh
et al., 2009). In addition, treatment of cells with chloroquine,
which inhibits acidiﬁcation of endolysosomes, also prevents STING
degradation (Konno et al., 2013).
STING is not the only pathway member to be regulated by
autophagy. When cGAS is bound to DNA in the cytoplasm, Beclin-1
binds cGAS and inhibits its enzymatic activity (Liang et al., 2014).
Upon cGAS binding, Beclin-1 releases the negative regulator of
autophagy, Rubicon, which allows for autolysosome maturation.
This autophagic response may be directly antiviral as opposed to
negatively regulating the cGAS/STING pathway. Knockdown of
Beclin-1 or cGAS reduces LC3 association and clearance of
foreign DNA.
Although the identiﬁcation of cGAS has contributed to our
understanding of innate immune sensing, a major conundrum still
exists in our understanding of how viral DNA is detected. Unlike
RNA viruses, many DNA viruses replicate in the nucleus of a cell.
One notable exception to this observation is poxvirus replication,
which occurs in the cytoplasm (Cairns, 1960). Without a lifecycle
in the cytoplasm, how are DNA viruses detected? One hypothesis
is that cGAS may bind incoming DNA viral genomes as they
traverse the cytoplasm. However, many DNA virus genomes are
protected by a viral capsid or travel to the nucleus through
membrane bound compartments (Whittaker et al., 2000; Tsai
and Qian, 2010), so this mechanism of sensing may only occur
during an abortive infection.
Before the discovery of cGAS, gamma-IFN-inducible protein 16
(IFI16) was identiﬁed as a nuclear DNA sensor necessary for the
induction of IFN during herpes simplex virus-1 (HSV-1) infection
(Unterholzner et al., 2010; Orzalli et al., 2012). IFI16 can trafﬁc
between the cytoplasm and nucleus, but at steady-state IFI16
localizes to the nucleus, allowing IFI16 to bind HSV-1 DNA and
activate IRF3 (Li et al., 2012). IFI16 also induces IFN expression in
response to HIV-1 single-stranded DNA and double-stranded DNA
replication intermediates (Jakobsen et al., 2013). Although IFI16-
induced IFN is STING-dependent, no direct activation of the STING
pathway by IFI16 has been demonstrated. Interestingly, IFN
induction during HSV-1 and HIV-1 infection is also dependent
on STING and cGAS (Sun et al., 2013; Gao et al., 2013). Given the
dual dependence on cGAS and IFI16, the sensors could potentially
cooperate to detect viral DNA where IFI16 could bind DNA in the
nucleus, trafﬁc to the cytoplasm, and subsequently interact with
cGAS to activate signaling through STING.
cGAS may also have a role in controlling RNA virus replication.
cGAS-deﬁcient mice display enhanced mortality to lethal chal-
lenges of the RNA virus West Nile virus (WNV) compared to
infections in wild-type mice (Schoggins et al., 2014). Additionally,
WNV infection of cGAS-deﬁcient macrophages leads to modestly
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increased viral titers compared to wild-type controls. This control
of viral replication is not due to direct recognition of RNA viruses
by cGAS because this enzyme is not activated by double-stranded
or single-stranded RNA (Sun et al., 2013; Zhang et al., 2014; Civril
et al., 2013). Rather, the role of cGAS in controlling RNA virus
infections may be linked to the observation that cGAS deﬁcient
cells exhibit decreased basal levels of ISGs. Low basal ISGs may
allow for a viral replication advantage from which the host cannot
recover, even if a robust IFN response is mounted later in infection.
Conclusion
Identifying innate immune sensors has been crucial to the
understanding of how a host defends itself from viral infection.
However, identiﬁcation is insufﬁcient, and these sensors must be
placed in a cell biological context. As such, the subcellular location
of these signaling pathways plays a major role in their function.
The localization of PRRs helps differentiate between host and
foreign nucleic acids, and the localization of downstream signaling
molecules can also have major effects on the signaling outcomes
that result. One theme slowly developing is that innate immune
sensing is not static and the movement of the sensors and their
immediate downstream effectors are of consequence. Understand-
ing how this dynamic behavior affects the function of sensors and
downstream signaling proteins will be important for our under-
standing of how the type-I IFN response is achieved.
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